Black veterans had 34 percent lower odds of screening completion versus White veterans

More patients taking alectinib with low-fat yogurt do not reach the exposure threshold of 435 ng/mL

Lack of significant overall survival advantage seen for indefinite-duration versus fixed-duration immunotherapy

Findings seen compared with stereotactic body radiotherapy for early-stage disease

Improvement seen compared with chemotherapy alone for first-line treatment of advanced non-small cell lung cancer

For ever smokers, log2-transformed years since smoking cessation before diagnosis associated with significantly lower mortality

Integration of definitive local therapy relevant if technically feasible and clinically safe to all disease sites

Benefits seen in terms of pathologic complete response and event-free survival for resectable non-small cell lung cancer

Company plans to stop selling the product globally this year

In subgroup analyses, lower risk was seen with cumulative dosage of ≥401 mg or with therapy duration of five years or longer